0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine Excipients Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-39N15088
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccine Excipients Market Research Report 2023
BUY CHAPTERS

Global Vaccine Excipients Market Research Report 2025

Code: QYRE-Auto-39N15088
Report
May 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vaccine Excipients Market

The global market for Vaccine Excipients was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
North American market for Vaccine Excipients is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Vaccine Excipients is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Vaccine Excipients include Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, GS, SEPPIC, Novavax, Dynavax Technologies, Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccine Excipients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Excipients.
The Vaccine Excipients market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccine Excipients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Excipients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vaccine Excipients Market Report

Report Metric Details
Report Name Vaccine Excipients Market
Segment by Type
  • Vaccine Stabilizers
  • Vaccine Emulsifiers
  • Vaccine Adjuvants
  • Preservatives
Segment by Application
  • Research Applications
  • Commercial Applications
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, GS, SEPPIC, Novavax, Dynavax Technologies, Sanofi, Zhifei Biological, Escon, Rico Bio, CSL Limited, Creative Biolabs, Central Drug House
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaccine Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaccine Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vaccine Excipients Market report?

Ans: The main players in the Vaccine Excipients Market are Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, GS, SEPPIC, Novavax, Dynavax Technologies, Sanofi, Zhifei Biological, Escon, Rico Bio, CSL Limited, Creative Biolabs, Central Drug House

What are the Application segmentation covered in the Vaccine Excipients Market report?

Ans: The Applications covered in the Vaccine Excipients Market report are Research Applications, Commercial Applications

What are the Type segmentation covered in the Vaccine Excipients Market report?

Ans: The Types covered in the Vaccine Excipients Market report are Vaccine Stabilizers, Vaccine Emulsifiers, Vaccine Adjuvants, Preservatives

Recommended Reports

Vaccine Applications

Excipient Market

Vaccine Logistics

1 Vaccine Excipients Market Overview
1.1 Product Definition
1.2 Vaccine Excipients by Type
1.2.1 Global Vaccine Excipients Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vaccine Stabilizers
1.2.3 Vaccine Emulsifiers
1.2.4 Vaccine Adjuvants
1.2.5 Preservatives
1.3 Vaccine Excipients by Application
1.3.1 Global Vaccine Excipients Market Value by Application (2024 VS 2031)
1.3.2 Research Applications
1.3.3 Commercial Applications
1.4 Global Vaccine Excipients Market Size Estimates and Forecasts
1.4.1 Global Vaccine Excipients Revenue 2020-2031
1.4.2 Global Vaccine Excipients Sales 2020-2031
1.4.3 Global Vaccine Excipients Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccine Excipients Market Competition by Manufacturers
2.1 Global Vaccine Excipients Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccine Excipients Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccine Excipients Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccine Excipients, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Excipients, Product Type & Application
2.7 Global Key Manufacturers of Vaccine Excipients, Date of Enter into This Industry
2.8 Global Vaccine Excipients Market Competitive Situation and Trends
2.8.1 Global Vaccine Excipients Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccine Excipients Players Market Share by Revenue
2.8.3 Global Vaccine Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccine Excipients Market Scenario by Region
3.1 Global Vaccine Excipients Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccine Excipients Sales by Region: 2020-2031
3.2.1 Global Vaccine Excipients Sales by Region: 2020-2025
3.2.2 Global Vaccine Excipients Sales by Region: 2026-2031
3.3 Global Vaccine Excipients Revenue by Region: 2020-2031
3.3.1 Global Vaccine Excipients Revenue by Region: 2020-2025
3.3.2 Global Vaccine Excipients Revenue by Region: 2026-2031
3.4 North America Vaccine Excipients Market Facts & Figures by Country
3.4.1 North America Vaccine Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccine Excipients Sales by Country (2020-2031)
3.4.3 North America Vaccine Excipients Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine Excipients Market Facts & Figures by Country
3.5.1 Europe Vaccine Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccine Excipients Sales by Country (2020-2031)
3.5.3 Europe Vaccine Excipients Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Excipients Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccine Excipients Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccine Excipients Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccine Excipients Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccine Excipients Market Facts & Figures by Country
3.7.1 Latin America Vaccine Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccine Excipients Sales by Country (2020-2031)
3.7.3 Latin America Vaccine Excipients Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccine Excipients Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccine Excipients Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine Excipients Sales by Type (2020-2031)
4.1.1 Global Vaccine Excipients Sales by Type (2020-2025)
4.1.2 Global Vaccine Excipients Sales by Type (2026-2031)
4.1.3 Global Vaccine Excipients Sales Market Share by Type (2020-2031)
4.2 Global Vaccine Excipients Revenue by Type (2020-2031)
4.2.1 Global Vaccine Excipients Revenue by Type (2020-2025)
4.2.2 Global Vaccine Excipients Revenue by Type (2026-2031)
4.2.3 Global Vaccine Excipients Revenue Market Share by Type (2020-2031)
4.3 Global Vaccine Excipients Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccine Excipients Sales by Application (2020-2031)
5.1.1 Global Vaccine Excipients Sales by Application (2020-2025)
5.1.2 Global Vaccine Excipients Sales by Application (2026-2031)
5.1.3 Global Vaccine Excipients Sales Market Share by Application (2020-2031)
5.2 Global Vaccine Excipients Revenue by Application (2020-2031)
5.2.1 Global Vaccine Excipients Revenue by Application (2020-2025)
5.2.2 Global Vaccine Excipients Revenue by Application (2026-2031)
5.2.3 Global Vaccine Excipients Revenue Market Share by Application (2020-2031)
5.3 Global Vaccine Excipients Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Curia
6.1.1 Curia Company Information
6.1.2 Curia Description and Business Overview
6.1.3 Curia Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Curia Vaccine Excipients Product Portfolio
6.1.5 Curia Recent Developments/Updates
6.2 Croda Pharma
6.2.1 Croda Pharma Company Information
6.2.2 Croda Pharma Description and Business Overview
6.2.3 Croda Pharma Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Croda Pharma Vaccine Excipients Product Portfolio
6.2.5 Croda Pharma Recent Developments/Updates
6.3 Alfa Chemistry
6.3.1 Alfa Chemistry Company Information
6.3.2 Alfa Chemistry Description and Business Overview
6.3.3 Alfa Chemistry Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Alfa Chemistry Vaccine Excipients Product Portfolio
6.3.5 Alfa Chemistry Recent Developments/Updates
6.4 A & C
6.4.1 A & C Company Information
6.4.2 A & C Description and Business Overview
6.4.3 A & C Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.4.4 A & C Vaccine Excipients Product Portfolio
6.4.5 A & C Recent Developments/Updates
6.5 Avantor
6.5.1 Avantor Company Information
6.5.2 Avantor Description and Business Overview
6.5.3 Avantor Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Avantor Vaccine Excipients Product Portfolio
6.5.5 Avantor Recent Developments/Updates
6.6 GS
6.6.1 GS Company Information
6.6.2 GS Description and Business Overview
6.6.3 GS Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GS Vaccine Excipients Product Portfolio
6.6.5 GS Recent Developments/Updates
6.7 SEPPIC
6.7.1 SEPPIC Company Information
6.7.2 SEPPIC Description and Business Overview
6.7.3 SEPPIC Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SEPPIC Vaccine Excipients Product Portfolio
6.7.5 SEPPIC Recent Developments/Updates
6.8 Novavax
6.8.1 Novavax Company Information
6.8.2 Novavax Description and Business Overview
6.8.3 Novavax Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novavax Vaccine Excipients Product Portfolio
6.8.5 Novavax Recent Developments/Updates
6.9 Dynavax Technologies
6.9.1 Dynavax Technologies Company Information
6.9.2 Dynavax Technologies Description and Business Overview
6.9.3 Dynavax Technologies Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Dynavax Technologies Vaccine Excipients Product Portfolio
6.9.5 Dynavax Technologies Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Company Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanofi Vaccine Excipients Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Zhifei Biological
6.11.1 Zhifei Biological Company Information
6.11.2 Zhifei Biological Description and Business Overview
6.11.3 Zhifei Biological Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zhifei Biological Vaccine Excipients Product Portfolio
6.11.5 Zhifei Biological Recent Developments/Updates
6.12 Escon
6.12.1 Escon Company Information
6.12.2 Escon Description and Business Overview
6.12.3 Escon Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Escon Vaccine Excipients Product Portfolio
6.12.5 Escon Recent Developments/Updates
6.13 Rico Bio
6.13.1 Rico Bio Company Information
6.13.2 Rico Bio Description and Business Overview
6.13.3 Rico Bio Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Rico Bio Vaccine Excipients Product Portfolio
6.13.5 Rico Bio Recent Developments/Updates
6.14 CSL Limited
6.14.1 CSL Limited Company Information
6.14.2 CSL Limited Description and Business Overview
6.14.3 CSL Limited Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CSL Limited Vaccine Excipients Product Portfolio
6.14.5 CSL Limited Recent Developments/Updates
6.15 Creative Biolabs
6.15.1 Creative Biolabs Company Information
6.15.2 Creative Biolabs Description and Business Overview
6.15.3 Creative Biolabs Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Creative Biolabs Vaccine Excipients Product Portfolio
6.15.5 Creative Biolabs Recent Developments/Updates
6.16 Central Drug House
6.16.1 Central Drug House Company Information
6.16.2 Central Drug House Description and Business Overview
6.16.3 Central Drug House Vaccine Excipients Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Central Drug House Vaccine Excipients Product Portfolio
6.16.5 Central Drug House Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Excipients Industry Chain Analysis
7.2 Vaccine Excipients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Excipients Production Mode & Process Analysis
7.4 Vaccine Excipients Sales and Marketing
7.4.1 Vaccine Excipients Sales Channels
7.4.2 Vaccine Excipients Distributors
7.5 Vaccine Excipients Customer Analysis
8 Vaccine Excipients Market Dynamics
8.1 Vaccine Excipients Industry Trends
8.2 Vaccine Excipients Market Drivers
8.3 Vaccine Excipients Market Challenges
8.4 Vaccine Excipients Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Vaccine Excipients Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vaccine Excipients Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vaccine Excipients Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vaccine Excipients Sales (kg) of Key Manufacturers (2020-2025)
 Table 5. Global Vaccine Excipients Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vaccine Excipients Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vaccine Excipients Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vaccine Excipients Average Price (US$/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vaccine Excipients, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vaccine Excipients, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vaccine Excipients, Product Type & Application
 Table 12. Global Key Manufacturers of Vaccine Excipients, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vaccine Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Excipients as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vaccine Excipients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vaccine Excipients Sales by Region (2020-2025) & (kg)
 Table 18. Global Vaccine Excipients Sales Market Share by Region (2020-2025)
 Table 19. Global Vaccine Excipients Sales by Region (2026-2031) & (kg)
 Table 20. Global Vaccine Excipients Sales Market Share by Region (2026-2031)
 Table 21. Global Vaccine Excipients Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vaccine Excipients Revenue Market Share by Region (2020-2025)
 Table 23. Global Vaccine Excipients Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vaccine Excipients Revenue Market Share by Region (2026-2031)
 Table 25. North America Vaccine Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vaccine Excipients Sales by Country (2020-2025) & (kg)
 Table 27. North America Vaccine Excipients Sales by Country (2026-2031) & (kg)
 Table 28. North America Vaccine Excipients Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vaccine Excipients Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vaccine Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vaccine Excipients Sales by Country (2020-2025) & (kg)
 Table 32. Europe Vaccine Excipients Sales by Country (2026-2031) & (kg)
 Table 33. Europe Vaccine Excipients Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vaccine Excipients Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vaccine Excipients Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vaccine Excipients Sales by Region (2020-2025) & (kg)
 Table 37. Asia Pacific Vaccine Excipients Sales by Region (2026-2031) & (kg)
 Table 38. Asia Pacific Vaccine Excipients Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vaccine Excipients Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vaccine Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vaccine Excipients Sales by Country (2020-2025) & (kg)
 Table 42. Latin America Vaccine Excipients Sales by Country (2026-2031) & (kg)
 Table 43. Latin America Vaccine Excipients Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccine Excipients Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vaccine Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vaccine Excipients Sales by Country (2020-2025) & (kg)
 Table 47. Middle East and Africa Vaccine Excipients Sales by Country (2026-2031) & (kg)
 Table 48. Middle East and Africa Vaccine Excipients Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vaccine Excipients Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vaccine Excipients Sales (kg) by Type (2020-2025)
 Table 51. Global Vaccine Excipients Sales (kg) by Type (2026-2031)
 Table 52. Global Vaccine Excipients Sales Market Share by Type (2020-2025)
 Table 53. Global Vaccine Excipients Sales Market Share by Type (2026-2031)
 Table 54. Global Vaccine Excipients Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vaccine Excipients Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vaccine Excipients Revenue Market Share by Type (2020-2025)
 Table 57. Global Vaccine Excipients Revenue Market Share by Type (2026-2031)
 Table 58. Global Vaccine Excipients Price (US$/g) by Type (2020-2025)
 Table 59. Global Vaccine Excipients Price (US$/g) by Type (2026-2031)
 Table 60. Global Vaccine Excipients Sales (kg) by Application (2020-2025)
 Table 61. Global Vaccine Excipients Sales (kg) by Application (2026-2031)
 Table 62. Global Vaccine Excipients Sales Market Share by Application (2020-2025)
 Table 63. Global Vaccine Excipients Sales Market Share by Application (2026-2031)
 Table 64. Global Vaccine Excipients Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vaccine Excipients Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vaccine Excipients Revenue Market Share by Application (2020-2025)
 Table 67. Global Vaccine Excipients Revenue Market Share by Application (2026-2031)
 Table 68. Global Vaccine Excipients Price (US$/g) by Application (2020-2025)
 Table 69. Global Vaccine Excipients Price (US$/g) by Application (2026-2031)
 Table 70. Curia Company Information
 Table 71. Curia Description and Business Overview
 Table 72. Curia Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Curia Vaccine Excipients Product
 Table 74. Curia Recent Developments/Updates
 Table 75. Croda Pharma Company Information
 Table 76. Croda Pharma Description and Business Overview
 Table 77. Croda Pharma Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. Croda Pharma Vaccine Excipients Product
 Table 79. Croda Pharma Recent Developments/Updates
 Table 80. Alfa Chemistry Company Information
 Table 81. Alfa Chemistry Description and Business Overview
 Table 82. Alfa Chemistry Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. Alfa Chemistry Vaccine Excipients Product
 Table 84. Alfa Chemistry Recent Developments/Updates
 Table 85. A & C Company Information
 Table 86. A & C Description and Business Overview
 Table 87. A & C Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. A & C Vaccine Excipients Product
 Table 89. A & C Recent Developments/Updates
 Table 90. Avantor Company Information
 Table 91. Avantor Description and Business Overview
 Table 92. Avantor Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. Avantor Vaccine Excipients Product
 Table 94. Avantor Recent Developments/Updates
 Table 95. GS Company Information
 Table 96. GS Description and Business Overview
 Table 97. GS Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. GS Vaccine Excipients Product
 Table 99. GS Recent Developments/Updates
 Table 100. SEPPIC Company Information
 Table 101. SEPPIC Description and Business Overview
 Table 102. SEPPIC Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 103. SEPPIC Vaccine Excipients Product
 Table 104. SEPPIC Recent Developments/Updates
 Table 105. Novavax Company Information
 Table 106. Novavax Description and Business Overview
 Table 107. Novavax Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 108. Novavax Vaccine Excipients Product
 Table 109. Novavax Recent Developments/Updates
 Table 110. Dynavax Technologies Company Information
 Table 111. Dynavax Technologies Description and Business Overview
 Table 112. Dynavax Technologies Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 113. Dynavax Technologies Vaccine Excipients Product
 Table 114. Dynavax Technologies Recent Developments/Updates
 Table 115. Sanofi Company Information
 Table 116. Sanofi Description and Business Overview
 Table 117. Sanofi Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 118. Sanofi Vaccine Excipients Product
 Table 119. Sanofi Recent Developments/Updates
 Table 120. Zhifei Biological Company Information
 Table 121. Zhifei Biological Description and Business Overview
 Table 122. Zhifei Biological Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 123. Zhifei Biological Vaccine Excipients Product
 Table 124. Zhifei Biological Recent Developments/Updates
 Table 125. Escon Company Information
 Table 126. Escon Description and Business Overview
 Table 127. Escon Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 128. Escon Vaccine Excipients Product
 Table 129. Escon Recent Developments/Updates
 Table 130. Rico Bio Company Information
 Table 131. Rico Bio Description and Business Overview
 Table 132. Rico Bio Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 133. Rico Bio Vaccine Excipients Product
 Table 134. Rico Bio Recent Developments/Updates
 Table 135. CSL Limited Company Information
 Table 136. CSL Limited Description and Business Overview
 Table 137. CSL Limited Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 138. CSL Limited Vaccine Excipients Product
 Table 139. CSL Limited Recent Developments/Updates
 Table 140. Creative Biolabs Company Information
 Table 141. Creative Biolabs Description and Business Overview
 Table 142. Creative Biolabs Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 143. Creative Biolabs Vaccine Excipients Product
 Table 144. Creative Biolabs Recent Developments/Updates
 Table 145. Central Drug House Company Information
 Table 146. Central Drug House Description and Business Overview
 Table 147. Central Drug House Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 148. Central Drug House Vaccine Excipients Product
 Table 149. Central Drug House Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Vaccine Excipients Distributors List
 Table 153. Vaccine Excipients Customers List
 Table 154. Vaccine Excipients Market Trends
 Table 155. Vaccine Excipients Market Drivers
 Table 156. Vaccine Excipients Market Challenges
 Table 157. Vaccine Excipients Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaccine Excipients
 Figure 2. Global Vaccine Excipients Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccine Excipients Market Share by Type: 2024 & 2031
 Figure 4. Vaccine Stabilizers Product Picture
 Figure 5. Vaccine Emulsifiers Product Picture
 Figure 6. Vaccine Adjuvants Product Picture
 Figure 7. Preservatives Product Picture
 Figure 8. Global Vaccine Excipients Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Vaccine Excipients Market Share by Application: 2024 & 2031
 Figure 10. Research Applications
 Figure 11. Commercial Applications
 Figure 12. Global Vaccine Excipients Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Vaccine Excipients Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Vaccine Excipients Sales (2020-2031) & (kg)
 Figure 15. Global Vaccine Excipients Average Price (US$/g) & (2020-2031)
 Figure 16. Vaccine Excipients Report Years Considered
 Figure 17. Vaccine Excipients Sales Share by Manufacturers in 2024
 Figure 18. Global Vaccine Excipients Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Vaccine Excipients Players: Market Share by Revenue in Vaccine Excipients in 2024
 Figure 20. Vaccine Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Vaccine Excipients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Vaccine Excipients Sales Market Share by Country (2020-2031)
 Figure 23. North America Vaccine Excipients Revenue Market Share by Country (2020-2031)
 Figure 24. United States Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Vaccine Excipients Sales Market Share by Country (2020-2031)
 Figure 27. Europe Vaccine Excipients Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Vaccine Excipients Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Vaccine Excipients Revenue Market Share by Region (2020-2031)
 Figure 35. China Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Vaccine Excipients Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Vaccine Excipients Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Vaccine Excipients Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Vaccine Excipients Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Vaccine Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Vaccine Excipients by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Vaccine Excipients by Type (2020-2031)
 Figure 54. Global Vaccine Excipients Price (US$/g) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Vaccine Excipients by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Vaccine Excipients by Application (2020-2031)
 Figure 57. Global Vaccine Excipients Price (US$/g) by Application (2020-2031)
 Figure 58. Vaccine Excipients Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS